CEimpact Podcast

CEimpact
  • 4.8 (17)
  • COURSES
  • UPDATED WEEKLY

The CEimpact Podcast features two shows:  GameChangers Clinical Updates  Precept2Practice GameChangers Clinical Update Series: The GameChangers podcast, hosted by Rachel Maynard, PharmD, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Listeners can purchase the episode to earn CE credit at: https://www.ceimpact.com/resources/podcast/  Precept2PracticeThe Precept2Practice podcast, hosted by Kathy Schott, brings you tools to mentor students and residents with confidence.  New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.Give us a follow, tune in regularly, and turn your drive time, coffee break, or chart review into a chance to level up your practice. CEimpact continuing education makes pharmacy learning inspiring!  Check back each week for our latest episodes. 

  1. The Role of Biosimilars in Managing Inflammatory Disease

    3D AGO

    The Role of Biosimilars in Managing Inflammatory Disease

    With the number of biosimilar products steadily increasing, pharmacists play a central role in ensuring their appropriate use in inflammatory conditions. This episode highlights approval pathways, interchangeability, and real-world challenges pharmacists may face when integrating biosimilars into care plans. You will walk away better prepared to support prescribers, counsel patients, and contribute to cost-effective, evidence-informed therapy decisions. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Reemal Zaheer, PharmD, CSP Pharmacist Johns Hopkins Medicine GAMECHANGERS CLINICAL UPDATE SERIES The Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that’s less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll.  PRACTICE RESOURCE Purchase the Clinical Update Series or this course individually to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here.   CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Explain the role of biosimilars in the treatment of inflammatory conditions. 2. Describe considerations for the pharmacist when evaluating or counseling on biosimilar therapies. Rachel Maynard and Reemal Zaheer have no relevant financial relationships with ineligible companies to disclose. 0.075 CEU/0.75 Hr UAN: 0107-0000-26-045-H01-P Initial release date: 2/2/2026 Expiration date: 2/2/2027 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    42 min
  2. FDA Removes Boxed Warnings on Menopausal Hormone Therapy

    JAN 26

    FDA Removes Boxed Warnings on Menopausal Hormone Therapy

    Menopausal hormone therapy has long carried a boxed warning (formerly a "black box warning") that may not accurately reflect the therapy's risk-benefit profile for all patients. This course discusses the FDA's recent removal of boxed warnings for select hormone therapy (HT) products, the rationale for this change, and how evolving guidance may impact patient care. You will explore strategies to support evidence-based counseling and individualized decision-making for patients considering HT. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Erin Raney, PharmD Professor Midwestern University College of Pharmacy GAMECHANGERS CLINICAL UPDATE SERIES The Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that’s less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll.  PRACTICE RESOURCE Purchase the Clinical Update Series or this course individually to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here or to purchase this course individually, click here.   CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize the FDA's updated position on boxed warnings for menopausal hormone therapy. 2. Identify key considerations for pharmacists when counseling patients about the benefits and risks of hormone therapy. Rachel Maynard and Erin Raney have no relevant financial relationships with ineligible companies to disclose. 0.075 CEU/0.75 Hr UAN: 0107-0000-26-044-H01-P Initial release date: 1/26/2026 Expiration date: 1/26/2027 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram Follow CEimpact on Social Media: LinkedIn Instagram

    42 min
  3. Key Updates on the Return of Ranitidine

    JAN 19

    Key Updates on the Return of Ranitidine

    Ranitidine — once withdrawn from the market over safety concerns — was recently re‑approved by the FDA in a reformulated version, raising important questions for pharmacists and patients alike. This course outlines the FDA’s recent approval, reviews the reformulated product's changes (including manufacturing and labeling), and examines practical considerations for dispensing, counseling, and patient safety. You will gain clarity on when ranitidine may be appropriate for use (again) and how to guide patients confidently in its safe use. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST K. Ashley Garling-Nanez, PharmD Assistant Director of Program UT Center of Health Communications GAMECHANGERS CLINICAL UPDATE SERIES The Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that’s less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll.  PRACTICE RESOURCE Purchase the Clinical Update Series or this course individually to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here.  CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Summarize the major safety and regulatory issues that prompted ranitidine's withdrawal, and the changes made in the reformulated product approved in 2025. 2. Describe pharmacist‑relevant considerations for dispensing, patient counseling, and transition from alternative acid‑reducing therapies. Rachel Maynard and K. Ashley Garling-Nanez have no relevant financial relationships with ineligible companies to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-043-H01-P Initial release date: 1/19/2026 Expiration date: 1/19/2027 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    32 min
  4. Whooping Cough and Measles Are Back

    JAN 12

    Whooping Cough and Measles Are Back

    Recent years have seen a troubling resurgence of whooping cough and measles — diseases many thought were largely controlled — highlighting the continuing importance of vaccination, surveillance, and community education. This course reviews the latest evidence on global and local trends, explores the factors driving renewed outbreaks, and discusses the key roles of pharmacists in prevention and early detection. You will gain insights to be better prepared to support immunization efforts, patient counseling, and public health awareness in response to this resurgence. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Christina O'Connor, PharmD, BCPS, BCIDP Clinical Pharmacy Manager Mayo Clinic GAMECHANGERS CLINICAL UPDATE SERIES The Clinical Update Series for Pharmacists delivers 52 expert-led podcast episodes and 30+ hours of clinically actionable continuing education, all for a one-time purchase of just $99—that’s less than $3 per hour for high-impact learning you can apply immediately in practice. Click here to enroll.  PRACTICE RESOURCE Purchase the Clinical Update Series or this course individually to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase the Clinical Update Series and claim your CPE credit, click here.  CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe recent epidemiologic trends in pertussis and measles resurgence and factors contributing to increased incidence. 2. Identify the pharmacist's responsibilities for promoting vaccination, encouraging timely immunization, supporting outbreak prevention, and providing patient education. Rachel Maynard and Christina O'Connor have no relevant financial relationships to disclose. 0.075 CEU/0.75 Hr UAN: 0107-0000-26-038-H01-P Initial release date: 1/12/2026 Expiration date: 1/12/2027 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    44 min
  5. The Great Debate of Steroid Use in CAP

    JAN 5

    The Great Debate of Steroid Use in CAP

    Corticosteroids in the treatment of community-acquired pneumonia (CAP) remain a topic of clinical curiosity and mixed opinions. In this unique episode, two expert guests share opposing perspectives—one advocating for corticosteroid use in CAP and the other urging caution—offering pharmacists a balanced view of the current evidence and practice considerations. Tune in to explore both sides of the debate and walk away with insights to inform your role in collaborative patient care. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUESTS Sam Markle, PharmD Critical Care Pharmacist Sanford Health Tristan Houle, PharmD PGY2 Critical Care Pharmacy Resident Sanford Health PRACTICE RESOURCE Purchase this course to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast. CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here. CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe current evidence supporting and challenging the use of corticosteroids in the treatment of community-acquired pneumonia (CAP). 2. Identify key considerations for pharmacists when evaluating corticosteroid use as adjunctive therapy in CAP. Rachel Maynard, Sam Markle, and Tristan Houle have no relevant financial relationships to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-26-032-H01-P Initial release date: 1/5/2026 Expiration date: 1/5/2027 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    37 min
  6. The Truth About Cannabis and Pregnancy Outcomes

    12/29/2025

    The Truth About Cannabis and Pregnancy Outcomes

    As cannabis becomes more widely available and socially accepted, so does the misconception that it's safe to use during pregnancy and lactation. This course reviews updated guidance from the American College of Obstetricians and Gynecologists (ACOG), highlighting the evidence behind the risks and outlining how pharmacists can address misinformation and counsel patients effectively. You will learn how to support safe, informed decision-making that promotes the health of both parent and child. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Kevin Shea, PharmD Pharmacist  Vytal Options  PRACTICE RESOURCE Purchase this course to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast.   CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here.  CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Identify current ACOG recommendations regarding cannabis use during pregnancy and lactation. 2. Describe pharmacist strategies for screening, counseling, and reducing risks associated with cannabis use during the perinatal period. Rachel Maynard and Kevin Shea have no relevant financial relationships to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-25-377-H01-P Initial release date: 12/29/2025 Expiration date: 12/29/2026 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    43 min
  7. Microdose Lithium in Alzheimer's Treatment

    12/22/2025

    Microdose Lithium in Alzheimer's Treatment

    Recent preclinical studies highlight the potential of micro‑dosed lithium to modulate Alzheimer’s disease pathology and support neuronal health. This episode examines the molecular mechanisms, current evidence in Alzheimer’s models, and emerging considerations for safe use and monitoring. You will gain insights to navigate this evolving topic and support informed discussions around lithium micro‑dosing in Alzheimer’s care. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Dawn Gerber, PharmD, BCGP, FASCP, FAzPA, CPAFH Professor of Pharmacy Practice Midwestern University PRACTICE RESOURCE Purchase this course to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast. CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here.  CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe current evidence on the use of microdose lithium in Alzheimer's disease. 2. Identify pharmacist considerations for monitoring, patient selection, and safety in the context of lithium micro-dosing for Alzheimer's. Rachel Maynard and Dawn Gerber have no relevant financial relationships to disclose. 0.05 CEU/0.5 Hr UAN: 0107-0000-25-375-H01-P Initial release date: 12/22/2025 Expiration date: 12/22/2026 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    39 min
  8. New Prescription Option for Fibromyalgia Treatment

    12/15/2025

    New Prescription Option for Fibromyalgia Treatment

    Patients with fibromyalgia have waited more than a decade for a new therapeutic option, and a recent regulatory approval signals a shift for these patients. This episode reviews the clinical trial data, mechanism of action, dosing considerations, and pharmacist‑relevant monitoring for the newly approved sublingual formulation of cyclobenzaprine HCl. You will gain practical insights to inform patient education, therapy optimization, and interdisciplinary collaboration in fibromyalgia care. HOST Rachel Maynard, PharmD GameChangers Podcast Host and Clinical Editor, CEimpact Lead Editor, Pyrls GUEST Amanda (Mandy) Mullins, PharmD, BCPS Clinical Pharmacist Practitioner Veterans Affairs PRACTICE RESOURCE Purchase this course to receive the exclusive downloadable practice resource handout to use as a reference guide to the podcast CPE REDEMPTION This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation: If you are already enrolled in this course, click here to redeem your credit. To purchase this episode and claim your CPE credit, click here.  CPE INFORMATION Learning Objectives Upon successful completion of this knowledge-based activity, participants should be able to: 1. Describe the mechanism of action and key clinical trial outcomes associated with the newly approved prescription medication for fibromyalgia. 2. Identify pharmacist responsibilities for dosing, monitoring adverse effects, and patient counseling when supporting the use of this new fibromyalgia therapy. Rachel Maynard and Amanda (Mandy) Mullins have no relevant financial relationships with ineligible companies to disclose.  0.05 CEU/0.5 Hr UAN: 0107-0000-25-371-H01-P Initial release date: 12/15/2025 Expiration date: 12/15/2026 Additional CPE details can be found here. Follow CEimpact on Social Media: LinkedIn Instagram

    46 min
See All (372)

4.8
out of 5
17 Ratings

About

The CEimpact Podcast features two shows:  GameChangers Clinical Updates  Precept2Practice GameChangers Clinical Update Series: The GameChangers podcast, hosted by Rachel Maynard, PharmD, features the latest game-changing pharmacotherapy advances impacting patient care. New episodes arrive every Monday. Listeners can purchase the episode to earn CE credit at: https://www.ceimpact.com/resources/podcast/  Precept2PracticeThe Precept2Practice podcast, hosted by Kathy Schott, brings you tools to mentor students and residents with confidence.  New episodes arrive on the third Wednesday of every month. Preceptor By Design™ subscribers can earn CE credit for each episode.Give us a follow, tune in regularly, and turn your drive time, coffee break, or chart review into a chance to level up your practice. CEimpact continuing education makes pharmacy learning inspiring!  Check back each week for our latest episodes. 

Information

  • Creator
    CEimpact
  • Years Active
    2021 - 2026
  • Episodes
    372
  • Rating
    Clean
  • Copyright
    © 2026 CEimpact Podcast
  • Show Website
    CEimpact Podcast

You Might Also Like